This raises the question: If both AMPK [43,48] and TORC1 [41] activities are elevated in ME/CFS cells, would we expect the rates of fatty acid catabolism to be increased or decreased? The gene discussed is CRTC1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.